- 3
- 0
- 约8.13千字
- 约 36页
- 2020-08-06 发布于湖北
- 举报
Adventitious Agent Testing of Novel Cell Substrates for Vaccine ManufactureArifa S. Khan, PhD.Division of Viral ProductsOffice of Vaccines Research and ReviewCBER, FDANovember 16, 2005;Outline
Cell substrates used in U.S. licensed viral vaccines
Safety concerns and challenges for testing novel cell substrates, especially tumorigenic cells
FDA experience with tumorigenic cell substrates
Testing recommendations for novel and tumorigenic cell substrates, such as Madin-Darby canine kidney (MDCK) cells;Types of Cell Substrates Used in Current U.S. Licensed Viral Vaccines;U.S. Licensed Viral
原创力文档

文档评论(0)